216 related articles for article (PubMed ID: 25146687)
21. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacogenetics/pharmacogenomics in psychiatry].
Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
[TBL] [Abstract][Full Text] [Related]
23. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.
Hiemke C
Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227
[TBL] [Abstract][Full Text] [Related]
25. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
26. Psychiatric pharmacogenomics in pediatric psychopharmacology.
Wall CA; Croarkin PE; Swintak C; Koplin BA
Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):773-88. PubMed ID: 23040901
[TBL] [Abstract][Full Text] [Related]
27. [Status of and perspectives on psychiatric genomic medicine].
Mors NP; Børglum AD
Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
[No Abstract] [Full Text] [Related]
28. [Current problems in geriatric psychopharmacotherapy].
Arushanian EB
Eksp Klin Farmakol; 2006; 69(6):43-50. PubMed ID: 17209465
[No Abstract] [Full Text] [Related]
29. Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?
Herbild L; Bech M; Gyrd-Hansen D; Christensen M; Werge T; Nielsen KA
Scand J Public Health; 2011 Mar; 39(2):147-55. PubMed ID: 21257648
[TBL] [Abstract][Full Text] [Related]
30. Toward a Global Roadmap for Precision Medicine in Psychiatry: Challenges and Opportunities.
Dalvie S; Koen N; McGregor N; O'Connell K; Warnich L; Ramesar R; Nievergelt CM; Stein DJ
OMICS; 2016 Oct; 20(10):557-564. PubMed ID: 27636104
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Lozupone M; Panza F; Stella E; La Montagna M; Bisceglia P; Miscio G; Galizia I; Daniele A; di Mauro L; Bellomo A; Logroscino G; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):259-277. PubMed ID: 27718745
[TBL] [Abstract][Full Text] [Related]
33. [Psychopharmacotherapy in the aged].
Pöldinger W; Krebs-Roubicek E
Verh Dtsch Ges Inn Med; 1990; 96():295-310. PubMed ID: 2092447
[No Abstract] [Full Text] [Related]
34. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
35. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
36. [Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry].
Linden M; Baier D; Beitinger H; Kohnen R; Osterheider M; Philipp M; Reimitz PE; Schaaf B; Weber HJ
Nervenarzt; 1994 Sep; 65(9):638-44. PubMed ID: 7991013
[No Abstract] [Full Text] [Related]
37. Should we be 'pushing meds'? The implications of pharmacogenomics.
Bray J; Clarke C; Brennan G; Muncey T
J Psychiatr Ment Health Nurs; 2008 Jun; 15(5):357-64. PubMed ID: 18454820
[TBL] [Abstract][Full Text] [Related]
38. [Psychopharmacotherapy in pathology of the internal organs].
Raĭskiĭ VA; Avrutskiĭ GIa
Ter Arkh; 1988; 60(10):51-5. PubMed ID: 3222749
[No Abstract] [Full Text] [Related]
39. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
Steimer W
Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
[TBL] [Abstract][Full Text] [Related]
40. [Safety of psychopharmacotherapy: a clinical and pharmacological approach].
Kirilochev OO; Umerova AR
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):127-133. PubMed ID: 31793554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
